With regards to VGSCs in breast cancer, a wealth of data has now confidently demonstrated that Nav1.5 and its splice variant nNav1.5 offers potential value as metastatic tumour markers in the diagnosis (including prognosis), and therapies of the disease. Here, SCN5A is linked to breast carcinoma.